Trial Profile
A phase I/II study of OTS167 for the treatment of acute myeloid leukemia
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 28 Mar 2016
Price :
$35
*
At a glance
- Drugs OTS 167 (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 28 Mar 2016 New trial record